Overview
Sporadic adult-onset ataxia of unknown etiology (SAOA), also referred to as idiopathic late-onset cerebellar ataxia (ILOCA) or sporadic adult-onset ataxia of unknown origin, is a progressive cerebellar degenerative disorder that occurs in adults without an identifiable genetic, metabolic, or acquired cause. It is classified as a diagnosis of exclusion, meaning it is established only after known hereditary ataxias (such as spinocerebellar ataxias and Friedreich ataxia), multiple system atrophy of the cerebellar type (MSA-C), and secondary causes of ataxia (such as alcohol, medications, autoimmune conditions, vitamin deficiencies, and structural lesions) have been thoroughly ruled out. The disease primarily affects the cerebellum and its connections, leading to progressive gait and limb ataxia, dysarthria (slurred or poorly coordinated speech), oculomotor abnormalities (such as nystagmus and impaired smooth pursuit), and impaired balance and coordination. Onset typically occurs after the age of 40, though it can present earlier in some individuals. The progression is generally slow compared to MSA-C, and patients usually do not develop the prominent autonomic dysfunction characteristic of multiple system atrophy. Some patients may also experience mild sensory neuropathy or pyramidal tract signs. Brain MRI typically reveals cerebellar atrophy, particularly of the vermis. There is currently no curative or disease-modifying treatment for SAOA. Management is supportive and symptomatic, focusing on physical therapy and rehabilitation to maintain mobility and balance, occupational therapy for daily living activities, and speech therapy for dysarthria. Assistive devices may be needed as the disease progresses. Regular neurological follow-up is important to monitor for any features that might suggest reclassification to a defined genetic ataxia or MSA-C, as some patients initially diagnosed with SAOA may later be found to have an identifiable cause with advances in genetic testing.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Sporadic adult-onset ataxia of unknown etiology.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Sporadic adult-onset ataxia of unknown etiology at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Sporadic adult-onset ataxia of unknown etiology.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Sporadic adult-onset ataxia of unknown etiology.
Community
No community posts yet. Be the first to share your experience with Sporadic adult-onset ataxia of unknown etiology.
Start the conversation →Latest news about Sporadic adult-onset ataxia of unknown etiology
No recent news articles for Sporadic adult-onset ataxia of unknown etiology.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Sporadic adult-onset ataxia of unknown etiology
What is Sporadic adult-onset ataxia of unknown etiology?
Sporadic adult-onset ataxia of unknown etiology (SAOA), also referred to as idiopathic late-onset cerebellar ataxia (ILOCA) or sporadic adult-onset ataxia of unknown origin, is a progressive cerebellar degenerative disorder that occurs in adults without an identifiable genetic, metabolic, or acquired cause. It is classified as a diagnosis of exclusion, meaning it is established only after known hereditary ataxias (such as spinocerebellar ataxias and Friedreich ataxia), multiple system atrophy of the cerebellar type (MSA-C), and secondary causes of ataxia (such as alcohol, medications, autoimmu
How is Sporadic adult-onset ataxia of unknown etiology inherited?
Sporadic adult-onset ataxia of unknown etiology follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Sporadic adult-onset ataxia of unknown etiology typically begin?
Typical onset of Sporadic adult-onset ataxia of unknown etiology is adult. Age of onset can vary across affected individuals.